Mithra and Mayne Pharma, its American partner, announced the commercial launch of Estelle (the oestrogen-based oral contraceptive from the Liège company) under the Nextstellis brand in the United States on Monday. This is the first and only pill based on Estetrol (E4), a native oestrogen that is now produced from plant sources. E4 is the first new oestrogen released in the United States in 50 years. Nextstellis was approved by the FDA, the American drug agency, last April.
Linked articles
Related articles
From Objectif Top Chef to Expo 2025 in Osaka, chef Alexandre Ciriello has established himself as the present and future of Walloon gastronomy.
The set design for the Belgian pavilion in Osaka was created by walloon Dirty Monitor and inspired by Japanese art
EHP, world leader in thermal control systems for the space industry
